| 书目名称 | Optimization of Pharmaceutical R&D Programs and Portfolios | | 副标题 | Design and Investmen | | 编辑 | Zoran Antonijevic | | 视频video | | | 概述 | Addresses the impact of study design on maximizing the output at the portfolio level in the pharmaceutical industry.Examines portfolio optimization comprehensively by integrating input from multiple s | | 图书封面 |  | | 描述 | .Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria..This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientis | | 出版日期 | Book 2015 | | 关键词 | Decision Analysis; Decision Making; Optimization; Pharmaceutical Portfolio; Portfolio Optimization; Quant | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-09075-7 | | isbn_softcover | 978-3-319-34312-9 | | isbn_ebook | 978-3-319-09075-7 | | copyright | Springer International Publishing Switzerland 2015 |
The information of publication is updating
|
|
发表于 2025-3-21 18:02:13
